Navigation Links
Study Finds Personal and Web-Based Support Equal Weight Loss Success
Date:3/11/2008

Kaiser Permanente Helps Members Achieve Weight Loss with Education &

Outreach

OAKLAND, Calif., March 11 /PRNewswire/ -- Findings in the Journal of the American Medical Association on the largest weight loss maintenance study to date reinforce Kaiser Permanente's approach to obesity prevention. The combination of both personal contact and web-based support are identified as the key to successful, long-term weight management. Kaiser Permanente's Center for Health Research in Portland, Ore., was the coordinating center for the Weight Loss Maintenance Trial of 1,032 overweight and obese adults and provided five of the study co-authors.

"The big discovery of this study is that losing weight and keeping it off is possible if you have ongoing, long-term support," said study second author Victor J. Stevens, Ph.D. a senior researcher at Kaiser Permanente's Center for Health Research. "Everyone in this country -- men, women, and children of every racial group -- is getting heavier because our society promotes eating too much and not getting enough exercise. We all need a personal health coach, and hopefully health care systems can provide that. That's why Kaiser Permanente does research: to find successful programs that fit into routine medical care, and that's what this study shows."

The study, presented at the American Heart Association's Nutrition, Physical Activity, and Metabolism Council Meeting in Colorado Springs, Colo., found that brief personal counseling and web-based intervention strategies offer the best hope in keeping weight off over three years. Of the study's participants, 287 were from Kaiser Permanente's Northwest region.

"The takeaway message of this study for people wanting to keep weight off long-term is: adopt a healthy diet; focus on lifestyle changes you can sustain; reduce calorie intake; keep notes daily on how much you eat and exercise; set specific, realistic goals you can meet;
'/>"/>

SOURCE Kaiser Permanente
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
2. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
3. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
4. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
5. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
6. Thomson Healthcare Cancer Profiler Used in Study
7. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
8. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
9. CMC, Moffitt Partner to Study Cancer
10. Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)
11. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015 Valeant Pharmaceuticals International, ... today announced the expiration of the tender offer (the ... to purchase all of the outstanding shares of Salix ... price of $173.00 per share in cash, without interest, ... midnight, Eastern time, on April 1, 2015.  Valeant expects ...
(Date:4/1/2015)... Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCBB: ... raw materials used in the manufacture of traditional Chinese medicine ... financial results for the three- and twelve-months ended December 31, ... 31,Twelve Months Ended December 31, 2014 , 2013 ... $686,669 , $998,934 $4,043,290 , ...
(Date:3/31/2015)... March 31, 2015 Neurocrine Biosciences, Inc. (Nasdaq: ... into an exclusive collaboration and licensing agreement for the ... Japan and other select Asian ... Tanabe intends to initially develop NBI-98854 in ... disease and tardive dyskinesia. Neurocrine retains full commercial rights ...
Breaking Medicine Technology:Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 3Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 2Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 3Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 4Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 5Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 6Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 7Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 8Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 9Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 10Yew Bio-Pharm Group Reports 2014 Fourth Quarter And Full Year Financial Results 11Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4
... Australia--(BUSINESS WIRE)--Jul 5, 2007 - Australian,biotechnology company Avexa ... blinded phase which,represents the first 24 week segment ... into the open-label section of the,trial (weeks 24 ... twice a day as part of their daily ...
... LAINATE, Italy - July 4, 2007 - Cosmo ... its,phase II/III study with CB-01-11 (Rifamycin SV MMX(tm)) ... that is not absorbed when taken in tablet ... delivers the active,ingredient into the colon, bacteria in ...
Cached Medicine Technology:Avexa's Apricitabine Clinical Trial Update 2Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2
(Date:4/1/2015)... 01, 2015 With so much wet weather ... spend much of their time indoors. When all this time ... air. The latest article from Clean Crawls offers ... in their homes. , One of the ways to ... to keep houseplants. The article states that, “Toluene, Xylene, and ...
(Date:4/1/2015)... Amercanex Corporation, today announced that Native ... Exchange and will conduct its wholesale business thru Amercanex ... exchange as one of the oldest and largest dispensaries ... stores in 9 locations with plans of expansion to ... excited to have Native Roots join Amercanex as they ...
(Date:4/1/2015)... 2015 Phybridge Inc., a provider ... today its strategic partnership with SaskTel in a ... the businesses of Saskatchewan. SaskTels’ Integrated Business Communications ... that offers users a hosted IP unified communications ... The objective of IBC is to offer an ...
(Date:4/1/2015)... 01, 2015 Eighty seven high schools ... from California Casualty . Many of the schools ... and subsequently have fewer and fewer dollars allocated to ... Casualty Chairman Emeritus Thomas R. Brown, who recognized that ... classroom. Since its inception in 2011, over $400,000 ...
(Date:4/1/2015)... "Giving credit where credit is due ... are inestimable." - Loretta Young , The American Water ... resources profession. The Call for Nominations for our ... a colleague, or organization for one of these awards. ... the AWRA Awards and view the nomination criteria and ...
Breaking Medicine News(10 mins):Health News:3 Simple Ways to Improve Home Air Quality Listed by Clean Crawls in Latest Article 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 2Health News:Amercanex, Native Roots form Exclusive Relationship to facilitate Wholesale Business 3Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 2Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 3Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 4Health News:California Casualty Teams Up With 87 High Schools, Awarding Over $100,000 in 2015 Thomas R. Brown Athletics Grants 5Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 2Health News:Nominations Sought for National Water Resources Awards and Student Scholarships 3
... as the third leading cause of death among adolescents ... (DU) study reveals inhaling or huffing vapors of common ... associated with increased suicidal thoughts and attempts. , Of ... solvents, 25 percent had attempted suicide, and 58 percent ...
... Times, Optimize Planning, Objectives and Offer Increased Clinical ... 29 Accuray,Incorporated (Nasdaq: ARAY ), a ... four new products designed to improve treatment times,optimize ... radiation delivery. These products are being launched at ...
... ... Healthcare Provider Earns $1.6 Million in Rebates This Year, Highlights ... Redwood City Project, ... the nation,s largest not-for-profit,health plan, will today celebrate significant energy efficiency upgrades,and solar ...
... quarter includes $1.8 million of first year milestone ... DUBLIN, Calif., Oct. 29 SuperGen Inc.,(Nasdaq: SUPG ... and commercialization of therapies for solid tumors and,hematological malignancies, ... months ended September 30, 2007. The Company reported ...
... are lots of other reasons to avoid the habit, experts ... be unhealthy in many other ways, but smoking does not ... cancer will have more aggressive or later-stage malignancy at the ... an analysis of data gathered on more than 6,000 women ...
... to Detect, Diagnose and,Personalize Treatment, WHAT: AdvaMed is holding a briefing ... media on the importance of molecular diagnostics in addressing ... community., ... African-Americans that, if caught earlier and managed more ...
Cached Medicine News:Health News:Study reveals 'huffing' household chemicals connected to teen suicide 2Health News:Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting 2Health News:Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting 3Health News:Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting 4Health News:Accuray Announces Four New Products at Nation's Leading Radiation Oncology Meeting 5Health News:The Healing Power of Green 2Health News:The Healing Power of Green 3Health News:SuperGen Reports 2007 Third Quarter Financial Results 2Health News:SuperGen Reports 2007 Third Quarter Financial Results 3Health News:SuperGen Reports 2007 Third Quarter Financial Results 4Health News:SuperGen Reports 2007 Third Quarter Financial Results 5Health News:SuperGen Reports 2007 Third Quarter Financial Results 6Health News:SuperGen Reports 2007 Third Quarter Financial Results 7Health News:SuperGen Reports 2007 Third Quarter Financial Results 8Health News:SuperGen Reports 2007 Third Quarter Financial Results 9Health News:SuperGen Reports 2007 Third Quarter Financial Results 10Health News:Smoking Does Not Worsen Breast Cancer 2Health News:Smoking Does Not Worsen Breast Cancer 3Health News:AdvaMed Convenes Panel to Address Health Disparities 2
... Penilab IV and the Penilab V have an exceptionally ... 1060 is similar to the Model 1061 shown below, ... be added later. The Penilab V has a ... the accessories you'll need to get started. Latex ...
The Model 240 is a single-channel instrument designed for penile tumescence monitoring. It features exceptional stability. It's ready for use with most multi-channel recorders having a DC input....
... MRI-Compatible Anesthesia System is perfect for larger surgery ... type of anesthetic agent. , ,The Integra ... its wider stance, has a larger work area. ... is utilized in both the Integra I and ...
... Market leader in soft tissue repair in ... has developed the latest evolution in orthopedic ... ORTHOCORD Suture is as strong as any ... importantly, ORTHOCORD Suture handles like ETHIBOND®., ,ORTHOCORD ...
Medicine Products: